Acceptability and safety of a new 3.0 ml re-usable insulin pen (HumaPen®) in clinical use

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 12, Issue 5, 1999, Pages 306-309

  Martin, Jane M ^a   Llewelyn, J A ^a   Ristic, S ^a   Bates, P C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Clinical study; Insulin injection device; Insulin pen

Indexed keywords

HUMULIN M; INSULIN; ISOPHANE INSULIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; SYRINGE;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPERGLYCEMIA; INJECTIONS; INSULIN; MALE; MIDDLE AGED; PATIENT EDUCATION; PATIENT SATISFACTION; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 0033429412     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Bashoff E.C., Beaser R.S.: Insulin therapy and the reluctant patient. Postgrad. Med. 97: 86-96, 1995.
2. ®, an injection device using cartridged insulin, for diabetic patients. Diabet. Med. 2: 496-497, 1985.
3. Hanas R., Ludvigsson J.: Experience of pain from insulin injections and needle phobia in young patients with IDDM. Practical Diabetes 14: 95-99, 1997.
4. Hornquist O., Wikby A., Stenstrom U., Andersson P.-O.: Change in quality of life along with type 1 diabetes. Diabetes Res. Clin. Pract. 28: 63-72, 1995.
5. Karlson B., Agardh C.-D.: Influence of intensified insulin regimen on quality of life and metabolic control in insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 25: 111-115, 1994.
6. Koivisto V., Chatterton N., Hicks D., Bates P.C., Llewelyn J.A.: Can involving diabetes specialists in developing a new pen result in patient benefits? Diab. Nutr. Metab. 12: 301-305, 1999.
7. Llewelyn J.A., Martin J., Bates P.C.: Patient acceptability and safety of a new 3.0 ml pre-filled insulin pen in a clinical setting. Practical Diabetes Int. 16: 79-81, 1999.
8. Kadiri A., Chraibi A., Marouan F., Ababou M.R., Guermai N.E., Wadjinny A., Kerfati A., Douiri M., Bensouda J.D., Belkhadir J., Arvanitis Y.: Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res. Clin. Pract. 41: 15-23, 1998.
9. Graff M.R., McClanahan M.A.: Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin. Ther. 20: 486-496, 1998.